FindMyKOL
Clinical trialNCT03814902CompletedInterventional

A Pilot Study to Characterize the Household Impact of Locating Devices for Children With ASD Who Wander

NCT03814902 is an interventional trial sponsored by Northwell Health. As of 21 Nov 2026, it is completed. It studies Autism Spectrum Disorder and Wandering Behavior. The registry lists an enrollment of 31 participants at 1 site in 1 country. The registry lists a start date of 15 Jan 2019 and a primary completion date of 11 Nov 2019.

SponsorNorthwell Health →Enrollment31Autism Spectrum DisorderWandering Behavior
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT03814902
FieldValue
Registry IDNCT03814902
StatusCompleted
Study typeInterventional trial
Lead sponsorNorthwell Health
Enrollment31
Registered sites1
Countries1
ConditionsAutism Spectrum Disorder and Wandering Behavior
Start15 Jan 2019
Primary completion11 Nov 2019
Study completion11 Nov 2019
Last update posted5 Jan 2021

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This pilot study will obtain preliminary data about the impact of wearable electronic tracking devices (ETDs) as an intervention for children with autism spectrum disorders (ASD) who wander. The feasibility of all study procedures and the acceptability of the intervention will be evaluated.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States1 site
  • Cohen Children's Medical Center of New York

    New Hyde Park

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 1 siteNY1MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT03814902

Each answer restates registry values shown on this page.

What is NCT03814902?

NCT03814902 is an interventional trial sponsored by Northwell Health. It studies Autism Spectrum Disorder and Wandering Behavior.

Who leads NCT03814902?

The registry names Andrew Adesman, MD (principal investigator, Northwell Health) as the overall official.

Where does NCT03814902 run?

The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.

When did NCT03814902 end?

The registry lists a primary completion date of 11 Nov 2019 and a study completion date of 11 Nov 2019. The sponsor last updated the record on 5 Jan 2021.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.